News – Page 7 – ContextVision

ContextVision Drives Medical Image Enhancement Innovation

ContextVision, Home, News 2020-12-02

ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, announces a progressive year of product innovation and talent acquisition. The company will virtually display its latest advancements in image enhancement as well as introduce new key staff to attendees of RSNA 2020.

Join us at RSNA 2020 – all-virtual event, November 29 – December 5

ContextVision, Home, Invitations, News 2020-11-23

Will we be meeting at RSNA this year? The exhibition will be an online event and you will be able to see our latest groundbreaking solutions in image enhancement.

ContextVision’s third quarter sees a recovery in sales and market entry in digital pathology is on track

ContextVision, Financial reports, Home, Investor News, News 2020-10-22

ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its third quarter.

Meet us at CMEF Autumn 2020

Invitations, News 2020-10-19

Meet us at CMEF Autumn 2020, October 19th-22nd. National Exhibition and Convention Center (Shanghai) (NECC), China John Xie 谢家农 / Sales Manager. E-mail:

Company presentation held at shareholder Webinar

ContextVision, Home, Investor News, News 2020-09-24

Today ContextVision presented the company at a shareholder webinar arranged by Norne and ContextVision. CEO Fredrik Palm gave an update of the company’s development and shared the company’s future direction. Please find a PDF-version of the presentation attached. The presentation will also be published on the company's website.

Invitation to company presentation

ContextVision, Investor News, News 2020-09-21

We are pleased to invite you to a presentation of Contextvision AB and its 2nd quarter and half year 2020 figures and give an update on the company’s development and ongoing projects. The presentation will be held as an online webinar on Thursday, September 24th at 11:30.

Mandatory notification of trade – primary insider

ContextVision, Home, Investor News, News 2020-08-28

Ola Lindblad, VP Medical Imgaing of ContextVision, has on August 27, 2020 purchased 1,800 shares in ContextVision AB at an average price of NOK 22.37 per share. After the transaction, Mr Lindblad holds a total of 6,300 shares in ContextVision AB.

ContextVision – Mandatory notification of trade – primary insider

ContextVision, Home, Investor News, News 2020-08-17

STOCKHOLM – August 17, 2020 – Fredrik Palm, CEO of ContextVision, has on August 17, 2020 purchased 200 shares in ContextVision AB at an average price of NOK 245 per share. After the transaction, Mr Palm holds a total of 2,820 shares in ContextVision AB. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 […]

ContextVision – key information relating to share split

ContextVision, Home, Investor News, News 2020-08-13

STOCKHOLM – Aug 13, 2020 – ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, today announces key information relating to the share spilt after a decision by the Board of Directors as of August 12th 2020. Reference is made to the extraordinary general meeting of ContextVision, held on August 5th, […]

ContextVision’s second quarter sees multiple product releases including digital pathology debut

Financial reports, Investor News, News 2020-08-13

ContextVision today reports a progressive second quarter. INIFY® Prostate Screening – the company’s first decision support tool in a planned digital pathology portfolio – was granted CE-mark status, paving the way for a strong entry into the fast-growing digital pathology market. In addition, the company continues to spearhead the image enhancement market with its new next-generation ultrasound product, Rivent®.